LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Tozasertib | 1.11 | uM | LJP5 | 2 | B15 | 72 | hr | 868 | 1011 | 3486 | 0.2900 | 0.0546 |
MDA-MB-231 | Tozasertib | 1.11 | uM | LJP5 | 3 | B15 | 72 | hr | 868 | 1160 | 3486 | 0.3327 | 0.1115 |
MDA-MB-231 | Trametinib | 1.11 | uM | LJP5 | 1 | P21 | 72 | hr | 868 | 1113 | 3486 | 0.3192 | 0.0935 |
MDA-MB-231 | Trametinib | 1.11 | uM | LJP5 | 2 | P21 | 72 | hr | 868 | 1128 | 3486 | 0.3235 | 0.0993 |
MDA-MB-231 | Trametinib | 1.11 | uM | LJP5 | 3 | P21 | 72 | hr | 868 | 1200 | 3486 | 0.3442 | 0.1268 |
MDA-MB-231 | TWS119 | 1.11 | uM | LJP5 | 1 | M03 | 72 | hr | 868 | 2848 | 3486 | 0.8169 | 0.7562 |
MDA-MB-231 | TWS119 | 1.11 | uM | LJP5 | 2 | M03 | 72 | hr | 868 | 2973 | 3486 | 0.8527 | 0.8039 |
MDA-MB-231 | TWS119 | 1.11 | uM | LJP5 | 3 | M03 | 72 | hr | 868 | 2942 | 3486 | 0.8439 | 0.7921 |
MDA-MB-231 | Vemurafenib | 1.11 | uM | LJP5 | 1 | C15 | 72 | hr | 868 | 2868 | 3486 | 0.8226 | 0.7638 |
MDA-MB-231 | Vemurafenib | 1.11 | uM | LJP5 | 2 | C15 | 72 | hr | 868 | 2560 | 3486 | 0.7343 | 0.6462 |
MDA-MB-231 | Vemurafenib | 1.11 | uM | LJP5 | 3 | C15 | 72 | hr | 868 | 3131 | 3486 | 0.8981 | 0.8643 |
MDA-MB-231 | Withaferin A | 1.11 | uM | LJP5 | 1 | G15 | 72 | hr | 868 | 1000 | 3486 | 0.2868 | 0.0504 |
MDA-MB-231 | Withaferin A | 1.11 | uM | LJP5 | 2 | G15 | 72 | hr | 868 | 988 | 3486 | 0.2834 | 0.0458 |
MDA-MB-231 | Withaferin A | 1.11 | uM | LJP5 | 3 | G15 | 72 | hr | 868 | 822 | 3486 | 0.2358 | -0.0176 |
MDA-MB-231 | Withaferin A | 1.11 | uM | LJP6 | 1 | G15 | 72 | hr | 868 | 827 | 3486 | 0.2372 | -0.0157 |
MDA-MB-231 | Withaferin A | 1.11 | uM | LJP6 | 2 | G15 | 72 | hr | 868 | 804 | 3486 | 0.2306 | -0.0245 |
MDA-MB-231 | Withaferin A | 1.11 | uM | LJP6 | 3 | G15 | 72 | hr | 868 | 792 | 3486 | 0.2272 | -0.0291 |
MDA-MB-231 | WYE-125132 | 1.11 | uM | LJP6 | 1 | L09 | 72 | hr | 868 | 1648 | 3486 | 0.4727 | 0.2979 |
MDA-MB-231 | WYE-125132 | 1.11 | uM | LJP6 | 2 | L09 | 72 | hr | 868 | 1783 | 3486 | 0.5114 | 0.3494 |
MDA-MB-231 | WYE-125132 | 1.11 | uM | LJP6 | 3 | L09 | 72 | hr | 868 | 1899 | 3486 | 0.5447 | 0.3937 |
MDA-MB-231 | WZ3105 | 1.11 | uM | LJP5 | 1 | D21 | 72 | hr | 868 | 719 | 3486 | 0.2062 | -0.0570 |
MDA-MB-231 | WZ3105 | 1.11 | uM | LJP5 | 2 | D21 | 72 | hr | 868 | 742 | 3486 | 0.2128 | -0.0482 |
MDA-MB-231 | WZ3105 | 1.11 | uM | LJP5 | 3 | D21 | 72 | hr | 868 | 705 | 3486 | 0.2022 | -0.0623 |
MDA-MB-231 | XMD11-50 | 1.11 | uM | LJP6 | 1 | P09 | 72 | hr | 868 | 1389 | 3486 | 0.3984 | 0.1989 |
MDA-MB-231 | XMD11-50 | 1.11 | uM | LJP6 | 2 | P09 | 72 | hr | 868 | 1487 | 3486 | 0.4265 | 0.2364 |